Department of Ophthalmology and Visual Sciences Archive — Page 8 of 10

December 16, 2014

Retinal neuron survival in glaucoma

Understanding how the protein TRPV1 helps neurons survive after glaucoma-related stressors could lead to new therapeutic strategies for glaucoma and other neurodegenerative conditions.

By Leigh MacMillan
AAAS logo with the tagline “ADVANCING SCIENCE, SERVING SOCIETY.”
November 24, 2014

Twelve Vanderbilt faculty elected AAAS fellows

Twelve members of Vanderbilt’s faculty have been elected fellows of the American Association for the Advancement of Science for their “scientifically or socially distinguished efforts to advance science or its applications.”

By Bill Snyder
October 16, 2014

Project PAVE’s impact on children’s vision easy to see

It’s been 20 years since Project PAVE, a Tennessee program providing low-vision evaluations for children, was launched.

By Jessica Pasley
Young child in a yellow shirt sits in a hospital bed, smiling while holding a small white object; an adult is partially visible beside the bed.
October 9, 2014

Novel therapy eases stress of retinoblastoma treatment

Conventional therapy for patients diagnosed with retinoblastoma, the most common ocular cancer in children, includes systemic chemotherapy, external beam radiation and/or surgical removal of the eye. Doctors at Vanderbilt University Medical Center are on track to radically change the way the disease is treated using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo.

By Jessica Pasley
Close-up of an older adult’s eye, showing a small circular implant visible in the iris area.
October 2, 2014

Regenerative visual neuroscience effort launched

Vanderbilt University has launched a regenerative visual neuroscience initiative to develop new ways of treating — and restoring sight to — people who have been blinded by glaucoma, macular degeneration, diabetic retinopathy and eye injuries.

By Bill Snyder
September 26, 2014

Biomarker for diabetic eye disease

A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies.

By Leigh MacMillan